Cougar Biotechnology, Inc.
Home | Careers | Contact | Site Map
Cougar Biotechnology, Inc.CompanyNewsLicensingResearch and DevelopmentInvestor Relations
Stock Information Analyst Coverage Events Media SEC Filings
Investor Relations

PDF »

Frequently Asked Questions

Q. What does Cougar Biotechnology do?
A.
Cougar is a development stage biopharmaceutical company based in Los Angeles, California that in-licenses novel therapeutics and develops such therapies for the treatment of cancer. Our strategy is to license technologies that have previously been tested in clinical trials, enabling us to obtain an initial indication of the drug's safety and biological activity in humans before committing capital to the drug's development.

Q. When was Cougar founded and where was it incorporated?
A.
Cougar was founded as a private company in May 2003 and incorporated in Delaware.

Q. When did Cougar become a publicly reporting company?
A.
On April 3, 2006, Cougar completed a reverse merger with a publicly reporting company SRKP 4, Inc., a Delaware corporation. The transaction was completed by the merger of a wholly-owned subsidiary of SRKP 4 with Cougar, with Cougar remaining as the surviving company and a wholly owned operating subsidiary of SRKP 4. SRKP 4 was renamed Cougar Biotechnology, Inc. following completion of the merger.

Q. On which exchange is Cougar's stock traded and what is its stock symbol?
A.
Cougar began trading on the OTC Bulletin Board® under the ticker symbol "CRGB.OB" on February 8, 2007. Cougar moved to The NASDAQ Global Market on December 7, 2007, and trades under the ticker symbol "CGRB".

Q. How many shares are outstanding?
A.
As of January 25, 2008, approximately 20.5 million shares of common stock were issued and outstanding. In addition, approximately 3.3 million shares are reserved for issuance according to the terms of the Company's 2003 Stock Option Plan, as amended.

Q. What is Cougar's CUSIP number?
A.
The CUSIP number for Cougar common stock is 222083107

Q. Does Cougar pay dividends on its common stock?
A.
No.

Q. Does Cougar offer a Direct Stock Purchase Plan?
A.
No

Q. Who is Cougar's transfer agent?
A.
Wells Fargo Shareowner ServicesSM

P.O. Box 64874
St. Paul, MN 55164-0874
1-800-468-9716
1-651-450-4064

Q. If I've lost my stock certificate or have a change of name or address, whom should I contact?
A.
Wells Fargo Shareowner ServicesSM
P.O. Box 64874
St. Paul, MN 55164-0874
1-800-468-9716
1-651-450-4064

Q. Who are Cougar's independent auditors?
A.
J.H. Cohn LLP, 4180 Ruffin Road, Suite 235, San Diego, CA 92123

Q. Who is Cougar's outside legal counsel?
A.
Fredrikson & Byron, P.A., 200 South Sixth Street, Suite 4000, Minneapolis, MN 55402

Q. When does Cougar's fiscal year end?
A.
December 31.

Q. When and where will Cougar's annual meeting of stockholders be held?
A.
The annual stockholders' meeting was held on Tuesday, June 17, 2008 at the Luxe Hotel Sunset Boulevard, 11461 Sunset Blvd., Los Angeles, CA 90049.

Q. Where are Cougar's headquarters located?
A.
Cougar's headquarters are located at 10990 Wilshire Blvd., Suite 1200, Los Angeles, CA 90024

Q. How can I get copies of Cougar's financial statements or other regulatory filings?
A.
Cougar's financial statements and other reports filed with the SEC are available on our Web site at www.cougarbiotechnology.com.

Q. If I have questions regarding the company, whom should I contact?
A.
Please contact Cougar's Investor Relations Department:
Telephone: 1-310-943-8040
Fax: 1-310-943-8059
Email: ir@cougarbiotechnology.com



Cougar Biotechnology, Inc.
10990 Wilshire Blvd, Suite 1200
Los Angeles, CA 90024
(310) 943-8040 Main
(310) 943-8059 Fax